Bone marrow lymphocyte dynamics and immunotherapeutic potential during chemotherapy in pediatric acute myeloid leukemia

Documenti analoghi

• Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study
  di: André Baruchel, et al.
  Pubblicazione: (2025)
• Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia
  di: Tulasi Geevar, et al.
  Pubblicazione: (2024)
• Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
  di: Amber Gibson, et al.
  Pubblicazione: (2024)
• CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia
  di: Alexandra Dreyzin, et al.
  Pubblicazione: (2025)
• A tumor-immune model of chronic myeloid leukemia with optimal immunotherapeutic protocols
  di: Zhang, Haifeng, et al.
  Pubblicazione: (2025)